OVERVIEW
The global market for pharmaceutical drug delivery is expected to reach USD 1.790 billion by 2024, growing over the forecast period at a CAGR of 6.13%. The growth in this market is driven mainly by the increasing prevalence of chronic diseases, development in the biologics industry, and advances in technology and the launch of new products.
TABLE OF CONTENT
1 Global Pharmaceutical Drug Delivery Market
1.1 Study Pharmaceutical Drug Delivery Market
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Pharmaceutical Drug Delivery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Pharmaceutical Drug Delivery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Pharmaceutical Drug Delivery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Pharmaceutical Drug Delivery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Pharmaceutical Drug Delivery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Pharmaceutical Drug Delivery Market – By Route of Administration (Market Size – &
million/billion)
8.1 Oral Drug Delivery
8.2 Pulmonary Drug Delivery
8.3 Injectable Drug Delivery
8.4 Ocular Drug Delivery
8.5 Nasal Drug Delivery
8.6 Topical Drug Delivery
8.7 Other
9 Global Pharmaceutical Drug Delivery Market – By Application
9.1 Infectious Diseases
9.2 Cancer
9.3 Cardiovascular Diseases
9.4 Diabetes
9.5 Respiratory Diseases
9.6 Central Nervous System Disorders
9.7 Autoimmune Diseases
10 Global Pharmaceutical Drug Delivery Market – By Facility of Use
10.1 Hospitals
10.2 Home Care Settings
10.3 ASC/Clinics
10.4 Diagnostic Centers
11 Global Pharmaceutical Drug Delivery Market – By Geography (Market Size – &
million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa
12 Global Pharmaceutical Drug Delivery Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships
13 Global Pharmaceutical Drug Delivery Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Johnson & Johnson Services, Inc.
13.3 Novartis AG
13.4 F. Hoffmann-La Roche Ltd.
13.5 3M
13.6 Merck & Co., Inc.
13.7 Pfizer, Inc.
13.8 Bayer AG
13.9 GlaxoSmithKline PLC
13.10 Antares Pharma, Inc.
13.11 Becton, Dickinson and Company
13.12 Company 11 & more
14 Global Pharmaceutical Drug Delivery Market – Appendix
14.1 Sources
14.2 Abbreviations